Total Funding
79
52
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9070
Parallel Bio develops tools that help in the discovery and development of immunotherapies.
- Juliana Hilliard: Co-Founder & CSOPast Role: System1 Biosciences, Staff Scientist, Organoid Development
- Robert DiFazio: Co-Founder & CEOPast Role: Stanford University School of Medicine, Director, Office of Strategy and Research Development
About the Company
Parallel Bio develops tools that help in the discovery and development of immunotherapies, to eliminate current barriers and create the fastest path to a drug that works. Parallel Bio's platform combines best-in-class human immune organoids with computational methods to generate unprecedented insights into human health and disease.
Women Founded
